Category: Stem Cell
Asia Stem Cell
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
APAC Stem Cell Therapy Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029 Market Segmentation: Asia-Pacific Stem Cell Therapy Market, Product Type ... Read More
-
Asia-Pacific Stem Cell Therapy Market Databank
... to 2029. Allogenic stem cell therapy segment is expected to be the highest contributor to this market, with $6,832.3 Million in 2020, and is anticipated to reach $8,851.5 Million by 2029, registering a CAGR of ... Read More
-
Medical Tourism Market (Procedure Type: Cardio [Internal Medicine], Cardiothoracic Surgery, Oncology, Fertility Treatments [IVF], Orthopedic Treatment, Dental Treatment, Ophthalmology, Aesthetics/Cosmetic Surgery, Neurology, Regenerative Therapy [Stem Cells], Medical Check-ups [Health Screening], and Others) - Malaysia Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Malaysia Medical Tourism Market – Scope of Report TMR’s report on the medical tourism market in Malaysia studies past as well as current growth trends and opportunities ... Read More
-
Middle East and Asia Pacific Cell and Gene Therapy Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - ... Read More
-
Adoptive Cell Therapy Market, by Type (CAR-T, TCR-T, NK, and TIL), By Application (Lymphoma, Leukemia, and Others), by End User (Hospitals and Cancer Treatment Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Adoptive cell therapy (ACT) is a type of immunotherapy in which T cells (a type of immune cell) are given to ... Read More
-
Stem Cell/Cord Blood Banking Global Market Report 2022 Including: 1) By Cell Type: Adult Stem Cells; Umbilical Cord Blood Stem Cells; Embryonic Stem Cells 2) By Service: Collection; Processing; Analysis; Storage 3) By Bank Type: Public; Private 4) By Application: Leukemia; Anemia; Thalassemia; Autism; Cerebral Palsy; Diabetes; Others Covering: AMAG Pharmaceuticals; Cordlife; Cryo-Cell International; Esperite; Americord Registry LLC; China Cord Blood Corporation
... report focuses on the stem cell/cord blood banking market which is experiencing strong growth. The report gives a guide to the stem cell/cord blood banking market which will be shaping and changing our lives over ... Read More
Research Assistance
